Nuvation Bio Inc.

NUVBNYSEHealthcare● Active

$4.80

$-0.02(-0.41%)

Market Cap$1.7B

P/E Ratio—

52W High$9.75

52W Low$1.57

Avg Volume4.0M

Open$4.91

Beta1.56

Forecast Market Cap PE Ratio

Nuvation Bio Inc.（NUVB）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

nuvb · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 9 位华尔街分析师

Buy

9 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 9 · 买入占比: 77.8%

12 个月目标价

High

$17.00

Consensus

$13.00

+170.8% upside

Low

$10.00

Median: $12.5 · Last Close: $4.80

Nuvation Bio Inc.（NUVB）的分析师共识为 Buy，基于过去 3 个月内 9 位华尔街分析师的评级。NUVB 的 12 个月平均目标价为 $13.00，相对当前价 $4.80 代表 +170.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $13 (170.8%)High $17Low $10

Consensus Target

$13.00

170.8% upside

High Target

$17

254.2%

Low Target

$10

108.3%

Current Price

$4.80

as of today

Based on analyst price targets, the NUVB stock price prediction for the next 12 months ranges from $10 to $17. The consensus NUVB price forecast of $13.00 implies 170.8% upside from the current price of $4.80.

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$4.91	↑ 2.36%	$4.88	$4.95

1-day model range: $4.88–$4.95. Peak: $4.95 (+2.36%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

29%21%50%

4Buy

3Neutral

7Sell

RSI (14)64.7Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · NUVB · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$4.88SELL

MA 10$4.83SELL

MA 20$4.71BUY

MA 50$4.69BUY

MA 100$4.98SELL

MA 200$0.00NEUTRAL

Current $NUVB · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$4.86SELL

EMA 10$4.82SELL

EMA 20$4.77BUY

EMA 50$4.83SELL

EMA 100$5.48SELL

EMA 200$0.00NEUTRAL

Current $NUVB · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-05-05	HC Wainwright & Co.	Maintains	Buy→Buy
2026-05-05	Wedbush	Maintains	Outperform→Outperform
2026-05-05	RBC Capital	Maintains	Outperform→Outperform
2026-04-16	Wedbush	Maintains	Outperform→Outperform
2026-04-02	Wedbush	Maintains	Outperform→Outperform
2026-03-27	Wedbush	Maintains	Outperform→Outperform
2026-03-03	UBS	Maintains	Neutral→Neutral
2026-03-03	RBC Capital	Maintains	Outperform→Outperform
2026-02-10	Wedbush	Maintains	Outperform→Outperform
2026-01-21	RBC Capital	Maintains	Outperform→Outperform

HC Wainwright & Co.2026-05-05

Maintains

Buy→Buy

Wedbush2026-05-05

Maintains

Outperform→Outperform

RBC Capital2026-05-05

Maintains

Outperform→Outperform

Wedbush2026-04-16

Maintains

Outperform→Outperform

Wedbush2026-04-02

Maintains

Outperform→Outperform

Wedbush2026-03-27

Maintains

Outperform→Outperform

UBS2026-03-03

Maintains

Neutral→Neutral

RBC Capital2026-03-03

Maintains

Outperform→Outperform

Wedbush2026-02-10

Maintains

Outperform→Outperform

RBC Capital2026-01-21

Maintains

Outperform→Outperform

Wall Street analysts have recently issued updated ratings on Nuvation Bio Inc. (NUVB) stock. Of the recent 55 rating actions, 2 were upgrades and 3 were downgrades. 9 analysts currently cover NUVB.

分析师推荐趋势

Buy ratings2 → 3↑ +1

Hold ratings0 → 0

Sell ratings0 → 0

NUVB analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$202M

↓ 47.7% YoY

Revenue Next Year

$290M

↑ 43.1% YoY

EPS This Year

$-0.36

EPS Next Year

$-0.26

↓ 26.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NUVB EPS of $-0.36 for the current fiscal year, based on estimates from 4 analysts. The NUVB revenue forecast is $202M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

NUVB 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NUVB 的共识目标价为 $13.00（+170.8% 上行空间），分析师共识为 Buy。

NUVB 的短期预测（明日）为 $4.91（+2.36%）。

Nuvation Bio Inc. 在 NYSE 上市，代码 NUVB。NUVB 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

NUVB 预测 · 8 个问题

根据 9 位华尔街分析师，NUVB 的 12 个月平均目标价为 $13.00，最高 $17.00、最低 $10.00。若有图表，中位目标价可在上方查看。相对当前价 $4.80，隐含约 +170.8% 的上行空间。

NUVB 目标价NUVB 分析师目标价NUVB 12个月目标价目标价 NUVB

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.